Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
This volatility comparison pits the dividend aristocrats ETF against the SP500 to help you evaluate relative risk and inform allocation decisions.
20,523 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A rally powered by a small group of tech stocks is raising concerns about the durability of trump’s bull market stand...
Genius Sports reported a significant top-line gain, with revenue up sharply last quarter. But a prominent investor ch...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
Alphabet is pursuing in-house AI chips and software, a strategy modeled on Apple’s vertical integration. The move cou...
Markets shift as the White House cools its push for rate cuts while Kevin Warsh faces inflation constraints. The 10-y...
Solana is often pitched as a blockchain that outpaces and underprices Ethereum. This article digs into why those adva...
A 50-year-old couple with $1.1 million in retirement savings faces 15 years of growth and withdrawals. With $50,000 s...
A renewed bond market selloff is sharpening focus on fiscal risks. Analysts say the u.s. debt ‘elephant room’ could q...
A cautious retirement strategy uses an eight-rung treasury bond ladder to aim for about $40,000 a year in stable inco...
As Palantir rolls out its Agentic AI Platform, analysts clash over value. This article breaks down the upside, the ri...
MicroStrategy, the world's largest corporate holder of Bitcoin, announced a major bond buyback this week, signaling a...